418 results on '"Salerno, Loredana"'
Search Results
2. Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects
3. Growing the molecular architecture of imidazole-like ligands in HO-1 complexes
4. A computer-aided approach to identify novel Leishmania major protein disulfide isomerase inhibitors for treatment of leishmaniasis
5. The Inhibition of Neuropathic Pain Incited by Nerve Injury and Accompanying Mood Disorders by New Heme Oxygenase-1 Inducers: Mechanisms Implicated
6. Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors
7. Progress in the development of more effective and safer analgesics for pain management
8. [1]Benzothieno[3,2-d]pyrimidine derivatives as ligands for the serotonergic 5-HT7 receptor
9. Non-competitive heme oxygenase-1 activity inhibitor reduces non-small cell lung cancer glutathione content and regulates cell proliferation
10. Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands
11. Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application
12. Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines
13. Novel Heme Oxygenase-1 Inducers Palliate Inflammatory Pain and Emotional Disorders by Regulating NLRP3 Inflammasome and Activating the Antioxidant Pathway
14. Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors
15. Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib
16. Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents
17. Heme oxygenase-1: A new druggable target in the management of chronic and acute myeloid leukemia
18. New N- and O-arylpiperazinylalkyl pyrimidines and 2-methylquinazolines derivatives as 5-HT7 and 5-HT1A receptor ligands: Synthesis, structure-activity relationships, and molecular modeling studies
19. Discovery of SI 1/20 and SI 1/22 as Mutual Prodrugs of 5‐Fluorouracil and Imidazole‐Based Heme Oxygenase 1 Inhibitor with Improved Cytotoxicity in DU145 Prostate Cancer Cells
20. In vitro and in silico analysis of imatinib analogues as anti-Trypanosoma cruzi drug candidates
21. Analysis of mechanisms for memory enhancement using novel and potent 5-HT1A receptor ligands
22. Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines
23. Structure–activity relationships and molecular modeling studies of novel arylpiperazinylalkyl 2-benzoxazolones and 2-benzothiazolones as 5-HT7 and 5-HT1A receptor ligands
24. High affinity ligands and potent antagonists for the α1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives
25. Heme Oxygenase Modulation Drives Ferroptosis in TNBC Cells
26. Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia
27. CAPE and its synthetic derivative VP961 restore BACH1/NRF2 axis in Down Syndrome
28. Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties
29. Antitumor properties of substituted (αE)-α-(1H-indol-3-ylmethylene)benzeneacetic acids or amides
30. Novel inhibitors of nitric oxide synthase with antioxidant properties
31. Synthesis and molecular modeling of 1H-pyrrolopyrimidine-2,4-dione derivatives as ligands for the α1-adrenoceptors
32. Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for α 1-adrenoceptor subtypes
33. Potential Health Benefits of a Pomegranate Extract, Rich in Phenolic Compounds, in Intestinal Inflammation
34. Mutual Prodrugs of 5‐Fluorouracil: From a Classic Chemotherapeutic Agent to Novel Potential Anticancer Drugs
35. Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent In Vitro Antiproliferative Activity
36. Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation
37. Potential health benefits of a pomegranate extract, rich in phenolic com-pounds, in intestinal inflammation
38. Combination of Heme Oxygenase-1 Inhibition and Sigma Receptor Modulation for Anticancer Activity
39. Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective
40. Glucose-Impaired Corneal Re-Epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate
41. Development of New Benzylpiperazine Derivatives as σ1 Receptor Ligands with in Vivo Antinociceptive and Anti-Allodynic Effects
42. Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation
43. Novel Heme Oxygenase-1 (HO-1) Inducers Based on Dimethyl Fumarate Structure
44. Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region
45. Evaluation of Imidazole-Based Compounds as Heme Oxygenase-1 Inhibitors
46. New 1,2,3,9-tetrahydro-4 H-carbazol-4-one derivatives: Analogues of HEAT as ligands for the α 1-adrenergic receptor subtypes
47. Chromatograpic resolution of phenylethanolic-azole racemic compounds highlighted stereoselective inhibition of heme oxygenase-1 by (R)-enantiomers
48. Synthesis and Molecular Modelling Studies of New 1,3-Diaryl-5-Oxo-Proline Derivatives as Endothelin Receptor Ligands
49. New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells
50. Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.